MetaCap

Crescent Biopharma Inc. Company Profile

NASDAQ: CBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.00+0.09 (+0.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Crescent Biopharma at a glance

Crescent Biopharma Inc. (NASDAQ: CBIO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Waltham, MA. Crescent Biopharma is led by Mr. Joshua T. Brumm and employs about 80 people. The company's shares have traded publicly since 2014.

At a market capitalization of $543.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001253689, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Crescent Biopharma do?

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.

Business description based on the company's public filings.

Company information

Legal name
Crescent Biopharma Inc.
Ticker
NASDAQ: CBIO
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Joshua T. Brumm
Employees
80
Headquarters
300 Fifth Avenue, Waltham, MA, United States
Phone
617 430 5595
IPO year
2014
Market cap
$543.21M
SEC CIK
0001253689
Latest annual report
10-K · Feb 26, 2026

Companies similar to Crescent Biopharma

CBIO peer companies
CompanyPrice% ChgMarket capCompare
AVBPArriVent BioPharma Inc.10.52-6.57%$544.13Mvs CBIO
ACRSAclaris Therapeutics Inc.3.44-1.71%$545.63Mvs CBIO
CLYMClimb Bio Inc.9.19-0.97%$539.80Mvs CBIO
ANLAdlai Nortye Group Ltd. ADR8.55-5.63%$550.60Mvs CBIO
BCAXBicara Therapeutics Inc.8.44-7.46%$560.31Mvs CBIO
GERNGeron Corporation0.8707-4.63%$560.94Mvs CBIO
ZVRAZevra Therapeutics Inc.8.76-3.42%$521.26Mvs CBIO
ALMSAlumis Inc.3.96-8.54%$514.09Mvs CBIO

Related